Wenbin Shen, PhD
Hebei Medical University Fourth Hospital
4
4
0
N/A
0
5
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (4)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Xiaojun Zhu, PhD
China National Institute for Occupational Safety and Health (NIOSH/CDC)
Shared therapeutic areas:
Elizabeth Krakow
Fred Hutch/University of Washington Cancer Consortium
Shared therapeutic areas:
Yan Sun, MD
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Shared therapeutic areas:
Worked with same sponsors:
Catherine ALIX-PANABIERES, Ph.D.
University Hospital, Montpellier
Shared therapeutic areas:
Qifa Liu
Nanfang Hospital, Southern Medical University
Shared therapeutic areas:
Ziming Li, MD
Shanghai Chest Hospital
Shared therapeutic areas:
Adolfo Martinez Tovar, PhD
Hospital General de Mexico
Shared therapeutic areas:
Kezhong Chen, MD
Peking University People's Hospital
Shared therapeutic areas:
Jun Yin, MD
Shanghai Zhongshan Hospital
Shared therapeutic areas:
Rong Yin, MD
Jiangsu Cancer Institute & Hospital
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (4)
Showing 4 of 4 trials
Durvalumab Combined With Chemoradiotherapy for Limited Stage Small Cell Lung Cancer (Camel-01)
Minimally Residual of Esophageal Cancer 001
Toripalimab Combined With Radiotherapy and S-1 for Older Patients With Esophageal Cancer
Immunotherapy Combined With Chemoradiotherapy for First-line Treatment of Esophageal Squamous Cell Carcinoma（ChinECR）
All 4 trials loaded